Lóránt Gönczi

The Burden of Inflammatory Bowel Disease in Europe in 2020

Mirabella Zhao, Lóránt Gönczi, Péter L. Lakatos et al. · Journal of Crohn s and Colitis · 2021 · 424 citations

Medicine, Internal Medicine, Surgery +15

Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease

Zsuzsanna Végh, Zsuzsanna Kürti, Lóránt Gönczi et al. · Scandinavian Journal of Gastroenterology · 2016 · 60 citations

Medicine, Clinical Sciences, Internal Medicine +17

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Lóránt Gönczi, K Gecse, Zsuzsanna Végh et al. · Inflammatory Bowel Diseases · 2017 · 57 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

Lóránt Gönczi, Zsuzsanna Végh, Petra A. Golovics et al. · Journal of Crohn s and Colitis · 2016 · 48 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database

Zsuzsanna Kürti, Zsuzsanna Végh, Petra A. Golovics et al. · Digestive and Liver Disease · 2016 · 41 citations

Pharmacy, Health Sciences, Pharmacotherapy +12